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A Multiplex Approach to Molecular Detection of Brucella abortus
and/or Mycobacterium bovis Infection in Cattle
SRINAND SREEVATSAN,1 JACK B. BOOKOUT,1* FIDEL RINGPIS,1 VEERA S. PERUMAALLA,2
THOMAS A. FICHT,2 L. GARRY ADAMS,2 SUE D. HAGIUS,3 PHILIP H. ELZER,3 BETSY J. BRICKER,4
GIRISH K. KUMAR,5 M. RAJASEKHAR,6 SRIKRISHNA ISLOOR,6 AND RAJ R. BARATHUR1
ClinCyte, LLC, San Diego, California 921211; Department of Veterinary Pathobiology, College of Veterinary Medicine,
Texas A&M University, College Station, Texas 77843-44672; Department of Veterinary Science, School of Veterinary
Medicine, Louisiana State University, Baton Rouge, Louisiana 708033; Division of Zoonotic Disease Research,
National Animal Disease Center, U.S. Department of Agriculture, Ames, Iowa 500104; Department of
Genetics and Plant Breeding, University of Agricultural Sciences, Bangalore, India 5600655; and
Institute of Animal Health and Veterinary Biologicals, Hebbal, Bangalore, India 5600246

A multiplex amplification and detection platform for the diagnosis of Mycobacterium bovis and Brucella
abortus infection simultaneously in bovine milk and nasal secretions was developed. This system (designated
the bovine pathogen detection assay [BPDA]-PCR) consists of duplex amplification of species-specific targets
(a region of the BCSP31K gene of B. abortus and a repeat-sequence region in the hsp65 gene of M. bovis,
respectively). This is followed by a solid-phase probe capture hybridization of amplicons for detection. On the
basis of spiking experiments with normal milk, the analytical sensitivity of the assay was 800 CFU equivalents/ml of milk for B. abortus and as low as 4 CFU equivalents per ml of milk for M. bovis. BPDA-PCR was
validated with 45 liver samples from lemmings experimentally infected with B. abortus. The assay sensitivity,
based on culture status as a “gold standard,” was 93.9%. In this experiment, BPDA-PCR also identified five
culture-negative liver samples as positive (41.7%). Field studies for the evaluation of BPDA-PCR were performed with samples from dairy animals from geographically distinct regions (India, Mexico, and Argentina).
A high prevalence of shedding of B. abortus (samples from India) and M. bovis (samples from Mexico) was
identified by BPDA-PCR. In samples from India, B. abortus shedding was identified in 86% of milk ring
test-positive animals (n ⴝ 15) and 80% of milk ring test-negative cows (n ⴝ 5). In samples from Mexico,
M. bovis was identified by PCR in 32.6% of pools (n ⴝ 46) of milk that each contained milk from 10 animals
and in 56.2% of nasal swabs (n ⴝ 121) from cattle from tuberculin test-positive herds. In contrast, the
Argentine cattle (n ⴝ 70) had a modest prevalence of M. bovis shedding in nasal swabs (2.9%) and milk (1.4%)
and of B. abortus in milk (11.4%). On the basis of these analyses, we identify BPDA-PCR as an optimal tool for
both screening of herds and testing of individual animals in a disease eradication program. A combination of
the duplex assay, screening of milk samples in pools, and the proposed algorithm provides a highly sensitive,
cost-effective, and economically viable alternative to serological testing.
America equivalent to about US$600 million annually, which
explains the priority given by animal health services to reducing the incidence of the disease (5). The World Health Organization reports an annual incidence of brucellosis in people of
less than 1 to 78 cases per 100,000 population in the Middle
East, with six countries reporting an annual total incidence of
over 90,000 cases. Among the Latin American countries, Argentina reports the largest incidence, followed by Mexico and
Peru (5, 37). Although brucellosis is a notifiable disease in
many countries, official figures do not fully reflect the number
of cases reported annually, and the true incidence has been
estimated to be between 10 and 25 times higher than what the
reported figures indicate (5).
Currently, identification of brucella-infected animals is
based on either the milk ring test, enzyme-linked immunosorbent assay (ELISA), or some PCR-based tests (on an experimental basis only) (2, 32, 33, 36). In addition, reports of brucellosis in free-ranging bison in Yellowstone National Forest
and the need to diagnose such infections rapidly and unambiguously (to prevent potential spillover of infection to domestic animal populations) reemphasize the necessity for the development of a molecular biology-based assay.
One-third of the world’s human population is infected with
Mycobacterium tuberculosis, and 3 million human deaths annu-

Animal health and human health are inextricably linked. For
millennia, humans have depended on animals for nutrition,
socioeconomic development, and companionship (1). Yet animals can transmit many different but potentially devastating
diseases to humans.
Brucellosis is a zoonosis of both public health and economic
importance in many developing countries (5, 24). Six species of
Brucella are presently known: B. abortus, B. suis, B. melitensis,
B. ovis, B. neotomae, and B. canis (1, 24). Brucellosis has been
effectively controlled in many developed or industrialized nations, thereby reducing the number of cases of brucellosis
among humans (5). Despite the preventive and control measures that exist in developed nations, there is still a high potential for transmission and spread of brucellae via animal
products imported from developing nations (1). Thus, animal
brucellosis poses a barrier for trade of animals and animal
products and could seriously impair socioeconomic progress in
the developing world (19, 20, 37).
Official estimates put losses due to brucellosis in Latin
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ally are attributable to the organism (1, 6). The pulmonary
form of zoonotic tuberculosis (TB) caused by Mycobacterium
bovis in humans is indistinguishable from the TB caused by M.
tuberculosis (strict sense) (7, 8, 31). Both species belong to the
M. tuberculosis complex group, which includes Mycobacterium
microti and Mycobacterium africanum (31). The four species
are closely related at the genetic level (with 95% DNA-DNA
homology) and are considered host specialists (31) on the basis
of their ability to cause disease in limited host populations.
However, M. bovis (considered the ancestral variant of the
other three species) has the widest host range including animals and humans (1, 31). Hence, animal TB poses a potential
source of TB in humans. In countries where bovine TB is
uncontrolled, most human cases occur in young persons and
result from the drinking or handling of contaminated milk or
milk products (1, 7, 8). Little is known about the frequency of
involvement of M. bovis in nonpulmonary TB in the developing
nations because of limited laboratory facilities for the culture
and identification (or typing) of tubercle bacilli (7; F. MiolanSuazo, M. Salman, J. Payeur, C. Ramirez, and J. Rhyan, Proc.
U.S. Anim. Health Assoc. Meeting, Tuberculosis session, p.
51–61, 1997).
Information on the incidence of human disease due to M.
bovis in developed and developing countries is scarce. A review
of zoonotic TB from 1954 to 1970 estimated that the proportion of cases due to M. bovis accounted for 3.1% of all forms of
TB: 2.1% of pulmonary forms and 9.4% of extrapulmonary
forms (7). The use of direct smear microscopy as the only
method for diagnosis of suspected TB, a requirement of any
national TB program, may partly explain the relatively low rate
of notification of disease due to M. bovis in developing countries (7). Direct smear microscopy (in addition to its low sensitivity) does not permit differentiation between species of the
M. tuberculosis complex; in addition, culture and species assignment, even when carried out, are time-consuming and not
confirmatory for the accurate identification of M. bovis (7, 16).
Currently, animal TB is diagnosed by a skin test that includes
a caudal fold, comparative cervical, single cervical, or doublestrength cervical test (1, 14; Miolan-Suazo et al., Proc. USAHA
Meeting). The skin test has a low sensitivity (65.6 to 70%) (25;
Miolan-Suazo, Proc. USAHA Meeting). Although some reports suggest that skin tests have a high specificity (98.8%)
(25), false-positive results due to exposure to atypical mycobacteria, corynebacteria, Fasciola hepatica (liver fluke), and/or
nocardia species are problematic in some countries. Alternate
tests including ELISA, lymphocyte stimulation tests, gamma
interferon assay (35), and blood tuberculosis battery tests are
useful but are complementary to skin tests rather than real
alternatives (25; Miolan-Suazo et al., Proc. USAHA Meeting).
In the absence of a highly sensitive and specific diagnostic
assay, prevention and control of these zoonoses is dependent
on the control and eradication of infection in animals, because
the transmission of these diseases is primarily from animals to
humans and is seldom between humans. This in turn is dependent upon a rapid, yet sensitive and specific means of detection
of brucellae or M. bovis organisms in potentially infective materials such as milk or nasal swabs. In this study we describe a
duplex amplification assay that can identify one or both organisms in a single reaction. The assay described herein is designed for milk samples and nasal swabs but can easily be
expanded to test other samples such as lymph node aspirates,
aborted fetal tissues, placental fluids or placenta from aborted
cows, lungs or lung lesions collected at necropsy, and nasal
aspirates.
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MATERIALS AND METHODS
Bacterial strains. (i) B. abortus. Purified genomic DNAs from two bovine
isolates (isolates NADC 8-1070 and NADC 8-0840), two vaccine strains (strains
RB51 and S19), and one type strain (strain 544) of B. abortus (3) were obtained
from the collection of the National Animal Disease Center (NADC), Ames,
Iowa, for development of the assay.
An aliquot of milk spiked with 109 CFU of strain 2308 (killed by pasteurization) per ml was obtained from the brucellosis laboratory of the Department of
Veterinary Science, Louisiana State University, Baton Rouge. Liver samples
from 46 experimentally infected lemmings were also provided for the evaluation
of the assay. The lemmings had been infected intraperitoneally with 103 CFU of
either strain 2308 or strain RB51 (10). Clearance of infection was monitored by
culturing the lemming liver samples collected aseptically after euthanasia.
(ii) M. tuberculosis complex. Whole-cell lysates enriched with genomic DNA
from 15 M. bovis strains and prepared with a mini-bead beater (15) were a
generous gift from the Tuberculosis Laboratory of the Centers for Disease
Control and Prevention, Atlanta, Ga. This set included 11 field isolates of M.
bovis, characterized on the basis of oxyR285 polymorphism (30), and four strains
of M. bovis BCG from the Trudeau Medical Collection (strains TMC1010,
TMC1002, TMC1029, and TMC1012). Six M. tuberculosis (strict sense) isolates
that had been characterized on the basis of IS6110 fingerprints and for mutations
in certain drug resistance-associated genes (rpoB, katG, and pncA) were obtained
from the Public Health Research Institute, New York, N.Y., and were analyzed
in this study.
A freeze-dried vaccine strain of BCG was used in spiking and serial dilution
experiments to define assay parameters.
Negative milk samples. A total of 10 raw milk samples were obtained from a
local herd in Colorado with no history of brucellosis or tuberculosis. The 10
samples were PCR tested for true-negative status. These samples were used in all
spiking experiments and in the entire study as negative controls for PCR with
milk.
The optical densities (ODs) of 63 negative samples (including negative milk
samples from a local disease-free herd [n ⫽ 10], samples from a disease-free herd
from Argentina [n ⫽ 16], PCR-negative controls [n ⫽ 27], and amplicons generated from Ehrlichia equi [n ⫽ 2], and Babesia microti [n ⫽ 2], and drug
resistance-associated gene-sequence regions from M. tuberculosis [two amplicons
each; katG, rpoB, and pncA]) were used to define a negative cutoff value (negative mean ⫾ 3 standard deviations).
DNA extraction (milk). In this study, DNA was extracted by using a 1-ml
aliquot of milk with a Boom extraction modification of a QIAamp Blood and
Tissue DNA Extraction protocol (34). Briefly, 1 ml of milk was centrifuged at
6,000 ⫻ g for 10 min. The clear whey portion was suctioned out with a transfer
pipette and discarded. The remaining milk solids and butterfat were used for
further processing and DNA extraction. Preheated sterile, double-distilled,
deionized water was used to bring the volume of the samples to 200 l, and the
mixture was vigorously vortexed to release the pellet from the bottom of the tube.
A total of 25 l of proteinase K (a 20-mg/ml stock) was added, and the mixture
was vortexed to mix. Subsequently, 200 l of preheated lysis buffer was added to
each tube, and the contents were vortexed again until the mixture was homogeneous. The mixture was then incubated at 70°C for 30 min. A second aliquot of
proteinase K was added, and the mixture was incubated at 70°C for an additional
30 min. After incubation, 210 l of ethanol was added, the mixture was vortexed,
and the samples were processed to DNA through QIAamp columns (catalog no.
29106; Qiagen, Valencia, Calif.) as described in the product insert (QIAamp
Blood and Body Fluids protocol; Qiagen). DNA was eluted in 200 l of sterile,
double-distilled, deionized water in all cases except where specified.
B. abortus (31-kDa protein or BCSP31K gene region). The gene that encodes
the 31-kDa protein is well conserved within the genus Brucella, with stretches of
nucleotide sequences that are species specific. A 311-bp region of the BCSP31K
gene (GenBank accession no. M20404) with four B. abortus-specific regions was
identified. The primers located at nucleotides 844 to 864 (5⬘-ACGCAGTCAG
ACGTTGCCTAT-3⬘) and nucleotides 1154 to 1131 (5⬘-TCCAGCGCACCATC
TTTCAGCCTC 3⬘) amplify a B. abortus-specific region (311 bp). A B. abortusspecific probe was designed by using this amplicon sequence and a series of
GenBank database searches. The design involved combination of two regions
within the amplicon so as to be able to capture both sense and antisense strands
of the amplicon. The probe used was 5⬘-CGACGATGGTGCCAGAAGATTT
GCGCCTTCTG-3⬘ (nucleotides 1035 to 1048 and 910 to 927). Since database
searches indicated that both the amplification primers and the probe were
unique to B. abortus, this region was used for assay development.
M. tuberculosis complex (putative host cell receptor binding protein [a segment of hsp65 gene with a region of direct-repeat sequences]). The hsp65 gene
is well conserved within the M. tuberculosis complex group and has stretches of
specific nucleotide sequences that can be used as probes. A direct-repeat segment in hsp65 gene (GenBank accession no. S46909) that contains four regions
specific for the M. tuberculosis complex was identified. The primers for one such
region located at nucleotides 272 to 293 (5⬘-GGCTGGTTACACCTTCGATG
CG-3⬘) and nucleotides 618 to 601 (5⬘-AGCCGCCGAAACCCATCT-3⬘) amplify an M. tuberculosis complex-specific region (347 bp). From this amplicon
sequence two M. tuberculosis complex-specific regions were identified by database searches. These regions could serve as a probe for the duplex assay. An M.
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TABLE 1. Source of field samples used to validate BPDA

Geographic locality

United States
Mexico
Mexico
India
Argentina

Animal
a

Laboratory animals
Bovine
Bovine
Bovine
Bovine

Specimen type

No. of samples

Comment

Liver
Milk
Nasal swabs
Milk
Milk, nasal swabs, lymph node aspirates

45
46b
121
20
128

Experimentally infected (B. abortus)
Bovine TB suspectc
Bovine TB suspectc
B. abortus suspectd
Infected and disease-free herdse

a

Operators were blinded as to the infection status of the lemming liver samples for this part of the study.
Pools of 10 samples each.
c
Suspicion of bovine TB was based on caudal fold tuberculin test or comparative cervical test positivity.
d
A subset of Indian samples (n ⫽ 15) was positive by the milk ring test. The other five samples were negative.
e
Argentine samples came from TB-positive herds (three herds) or herds with brucellosis (two herds). One disease-free herd was sampled as a control.

tuberculosis complex-specific probe was designed to capture both sense and
antisense strands of the amplicon. The probe sequence identified was 5⬘-ACAT
CGGCAACAACAACATCGGC-TGCCGGTGTTGCCGCT-3⬘ (nucleotides 406
to 426 and 506 to 488). The probes have more than one homologous site within
the 347-bp amplicon and may enhance the probability of successful hybridization
even under very high stringency conditions. Since BLAST database searches
indicated that both the amplification primers and probes were unique to M. tuberculosis complex, this region was used for the assay development.
Internal standard (bovine ␤2-microglobulin). An internal amplification control was designed and used with all samples to assess the integrity of DNA
(during transport at room temperature) and the absence (or presence) of PCR
inhibitors in the sample. A 226-bp stretch of the bovine ␤2-microglobulin sequence (GenBank accession no. X69804) was used as an internal standard.
Specific forward and reverse primer sequences at nucleotides 135 to 155 (5⬘ACCTGAACTGCTATGTGTATG-3⬘) and nucleotides 360 to 340 (5⬘-TCT
CGATCCCACTTAACCTATC-3⬘), respectively, were identified by database
searches, as described above for the other two targets. A ␤2-microglobulin probe
(nucleotides 207 to 240; 5⬘-TTAAATCGGAGCAGTCAGACCTGTCTTTCAG
CAA-3⬘) was also designed for the solid-phase detection assay.
Duplex amplification. Experiments for amplification of either M. bovis alone,
B. abortus alone, or the two organisms in combination were performed with
genomic DNA purified from the respective bacterial cultures. All four primers
used in the amplification reactions were biotinylated. The amplification conditions and master-mixture components (MgCl2 concentration and primer concentrations) were optimized to amplify all DNAs as singlets or in 15 different
combinations of B. abortus and M. bovis as duplexes. The master-mixture composition used for a 50-l reaction mixture was 10⫻ PCR buffer (with 15 mM
MgCl2; Perkin-Elmer, Branchburg, N.J.), deoxynucleoside triphosphates (final
concentration, 200 M; Pharmacia), M. tuberculosis complex-specific sense and
antisense primers (final concentration, 1 M), B. abortus-specific primers
(final concentration, 0.25 M), 2.5 l of genomic DNA from pure bacterial
cultures (10 l of DNA was used for extracts from all primary clinical samples
including nasal swabs, lymph nodes, vaginal swabs, and milk), and Taq polymerase (2.5 U per reaction mixture). The thermal cycler parameters used for amplification were initial denaturation at 95°C for 2 min, followed by 35 cycles of
denaturation at 94°C for 15 s, annealing at 62°C for 20 s, and extension at 72°C
for 20 s. At the end of 35 cycles, a final extension step at 72°C for 7 min was
performed.
Solid-phase hybridization and detection. The species-specific probes were
designed to target a well-conserved region within the amplicon of interest. The
specificities of the probes were identified by a series of GenBank database
searches. Each probe was resuspended in freshly prepared 1 M ammonium
acetate solution (pH 7.5). M. tuberculosis complex-specific probe was used at a
concentration of 50 ng/100 l, while the B. abortus-specific probe was used at 75
ng/100 l. For screening for both pathogens in one well, both probes were added
in one solution at the concentrations indicated above. For the detection of
individual pathogens, only one specified probe was used per coating solution.
Each well of the microtiter plates was coated with 100 l of the solution that
contained the probes, and the plates were incubated at 37°C overnight. After
overnight incubation, the plates were washed twice with phosphate-buffered
saline (PBS)–Tween 20 and were then blocked with PBS–1% bovine serum
albumin for 2 h at 37°C. The plates were washed twice with PBS–Tween 20, air
dried, and stored in airtight sachets with desiccant at 4°C until they were used.
On the basis of a series of optimization experiments with different salts (guanidium thiocyanate or sodium thiocyanate [NaSCN]) and concentrations (1 and
2.5 M) for hybridization, 1 M NaSCN (pH 5.0 ⫾ 0.2) was identified as the ideal
neutralization-hybridization buffer for the duplex detection protocol. Briefly,
25-l aliquots of the denatured amplicons were loaded into precoated microtiter
plate wells that contained 100 l of hybridization buffer (1 M NaSCN). The
plates were incubated at 37°C for 1 h. The plates were then washed five times
with PBS–Tween 20. A 100-l aliquot of a 1:2,500 dilution of neutravidinperoxidase (Pierce) was added to each well, and the plate was incubated for 15
min at 37°C. The plates were washed seven times with PBS–Tween 20, and 100
l of tetramethylbenzidine (Moss Inc., Pasadena, Md.) was added to each well.

The plates were incubated in the dark for 10 min at room temperature. The
reaction was stopped with 5% sulfuric acid (100 l/well), and the plates were
read at 450 nm with an automated ELISA Reader (Bartels Prima System; Baxter
Scientific).
The background and nonspecific reactivities were tested by using negative
controls that consisted of the amplification reaction mixture, amplicons that
targeted other drug resistance-associated regions in M. tuberculosis (katG, pncA,
rpoB), and 16S rRNA amplicons from other organisms such as B. microti and
E. equi. These served as within-species and other extraneous negative controls.
Field studies. The sources of the field samples for these studies are described
in Table 1. Animals from brucella buffered antigen plate agglutination test- or
caudal fold test-positive and -negative herds from a variety of geographic localities were sampled (Table 1) and were analyzed by the bovine pathogen detection
assay (BPDA)-PCR. The samples included milk (n ⫽ 136), nasal swabs (n ⫽
149), lymph nodes aspirates (n ⫽ 7), and other specimens (n ⫽ 9).
The samples originated from Mexico, Argentina, and India. All samples were
processed to DNA at local laboratories with appropriate biosafety facilities. The
DNA was analyzed at the ClinCyte laboratory in San Diego, Calif.
(i) Herd sampling in Argentina. A total of 128 bovine samples were obtained
from farms that were classified as either “brucellosis positive” (defined by reactivity in a buffered plate antigen assay), “TB positive” (defined by delayed hypersensitivity to an intradermal injection of purified protein derivative), or disease-free (defined by a negative skin test and a negative buffered plate antigen
assay result). The samples included milk (n ⫽ 70), nasal swabs (n ⫽ 28), retropharyngeal lymph node aspirates (m ⫽ 7), and historical samples from a slaughterhouse (vaginal and lymph node swabs) (n ⫽ 9). Fourteen pools of five individual milk samples each were also analyzed. Table 2 gives the stratified sampling
scheme used for this study.
(ii) Samples from TB-positive herds in Mexico. Two bovine TB-suspect herds
(considered heavily infected, as indicated by caudal fold test results) were sampled. Nasal swabs (n ⫽ 121) and milk samples (n ⫽ 460) were collected. The milk
samples were pooled into batches of 10 milk samples each, and the DNA was
analyzed at the ClinCyte laboratory.
(iii) Bovine brucellosis-positive milk samples from India. Milk was sampled
from 20 dairy cows either positive (n ⫽ 15) or negative (n ⫽ 5) for brucellosis as
determined by the milk ring test. DNA was extracted in a local laboratory and
was analyzed by BPDA-PCR at the ClinCyte laboratory.
Milk collection technique. All milk samples were obtained from animals during their routine milking time. This approach prevented disruption of farmers’
day-to-day on-farm operations and simplified sample collection. The samples
from each animal were obtained from all four quarters of the mammary gland.

TABLE 2. Summary of samples collected in two
Argentine counties for BPDA-PCR
Suspected pathogen
on farma

No. of samples
Milk

Nasal
swabs

Lymph node
aspirates

7

M. bovis
M. bovis
M. bovis
B. abortus
B. abortus
“Negative” farm

16
6
10
18
10
10

16
6

Total samples collected

70

28

a

Other (lymph
node swabs)

6
7

9

Suspicion of M. bovis infection was based on purified protein derivativepositive status, and that for B. abortus infection was based on brucella BAPA
test-positive status.
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FIG. 1. (Top panel) Agarose gel electrophoretic pattern of amplicons generated from genomic DNA of M. bovis alone (lane 1), M. bovis and B. abortus (clinical
strain 8-1070) mixed (lane 2), M. bovis and B. abortus (vaccine strain RB51) mixed (lane 3), or B. abortus alone (strain 8-1070 in lane 4 and RB51 in lane 5). (Bottom
panel) Related ODs at 450 nm recorded for each amplicon when probed with either the M. bovis (Mb) probe alone ( ), the B. abortus (Ba) probe alone ( ), or a
combination of both probes (䊐). Also shown ( ) are the ODs at 450 nm of blank wells (negative controls). Clear increases in ODs are noted for each individual
amplicon with species-specific probes with no evidence of cross-reactivity (lanes 1, 4, and 5), while reactivity with both probes was seen when both amplicons were
present (lane 2). Blank wells were negative throughout.

,

Collections were done after thorough disinfection of the teat area with povidone
iodine. The milk sampler’s (veterinarian’s) gloves were also disinfected and
wiped dry between samplings. Two to three strippings of milk from each teat
were drawn into a sterile 50-ml tube, and the tubes were capped and stored on
ice until further use. The entire collection process involved only two technicians
(one who collected the milk and one who assisted) to rapidly obtain samples
from the 16 to 24 animals in the entire milking shed at a time.
Nasal swab collections. Animals were individually restrained in a trevis or
chute with a nose ring, which kept their necks extended. Both nasal passages of
each animal were swabbed. Sterile applicators were applied deep into the nostrils, the nostril was vigorously scrubbed two to three times, and the applicator
was placed in a sterile tube. The swabs were rehydrated with 500 l of sterile
water and were vortexed before an aliquot was taken for DNA extraction.
Lymph node aspirates. Retropharyngeal lymph node aspirates were collected
while the animals were restrained in a chute. An 18-gauge (1.5-in) needle attached to a 10-ml syringe was inserted into the lymph node, and an aspirate was
obtained. Aspirates were transferred to a sterile 15-ml tube and transported on
ice. The tubes were vortexed, and a 200-l aliquot was taken for DNA extraction.

RESULTS
Duplex amplification (initial setup and optimization). Experiments for amplification of either M. bovis alone, B. abortus
alone, or the two organisms in combination were performed
with the following genomic DNAs purified from the respective
bacterial cultures: DNAs from 10 M. bovis strains (including 2
TMC strains, 1 BCG vaccine strain, and 7 field isolates), DNAs
from 2 M. tuberculosis strains (patient isolates), and DNAs

from 5 B. abortus strains (including 2 bovine isolates, type
strain 544, and 2 vaccine strains). The amplification conditions
and master mixture components were optimized to amplify all
DNAs as singlets or in different combinations of B. abortus and
M. bovis as duplexes (Fig. 1).
The negative cutoff value of 0.200 for the assay was based on
the average ODs for all negative samples ⫹ 3 standard deviations.
Analytical sensitivity estimations. (i) Serially diluted M. bovis and B. abortus amplicons. M. bovis and B. abortus amplicons
were generated and column purified (Hi-Pure; Boehringer
Mannheim) to remove excess primers. The copy number in
each amplicon was determined by using the estimated DNA
concentration (calculations were based on the absorbance at
an OD of 260 nm and amplicon size). Equal numbers of copies
of each amplicon were mixed and serially diluted (2 ⫻ 105, 2 ⫻
104, 2 ⫻ 103, 2 ⫻ 102, and 2 ⫻ 101 copies per reaction mixture),
and the amplicons were then reamplified. The reamplified
amplicons were analyzed by agarose gel electrophoresis and
solid-phase probe-capture hybridization and detection as
described above. The analytical sensitivity in this amplicon
dilution experiment was 20 copies (on the basis of the lowest
copy number used in the analysis) for amplicons of both
pathogens.
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(ii) Serial dilution of B. abortus genomic DNA in milk. One
milliliter of normal raw cow milk was spiked with from 200 ng
to 0.002 pg of B. abortus DNA (i.e., at equivalents of 2 ⫻ 108
to 2 genomes). The copy number (or genome equivalent) estimates were calculated on the basis of the fact that 100 fg of
B. abortus DNA is equivalent to 20 organisms (P. H. Elzer,
personal communication, 1999). One aliquot of milk was not
spiked and was used as a negative control. The DNA was
reextracted from the milk by the protocol described above.
Forty microliters of the reextracted DNA was amplified as
described above and was analyzed on a microtiter plate. By this
analysis the analytical sensitivity of the assay was 40 genome
equivalents per reaction mixture by microtiter plate detection.
(iii) Serial dilution of B. abortus organisms in milk. Strain
2308 of B. abortus was spiked into a sample of milk at 109
CFU/ml, and the mixture was pasteurized. An aliquot of this
was serially diluted (108 to 0 CFU/ml) in raw milk from a
healthy cow, and DNA was extracted in 200 l of distilled
deionized water. Ten microliters of this DNA was PCR amplified and was detected by microtiter plate analysis. The results
of this analysis indicated that the assay could detect down to
1 ⫻ 102 CFU equivalents of B. abortus per reaction mixture (or
2 ⫻ 103 CFU equivalents/ml of milk).
Since the results obtained with whole-cell dilutions and
genomic DNA dilutions are more accurate than those obtained
with amplicons, the analytical sensitivity of the assay was estimated to be 40 to 100 CFU/reaction mixture (or 800 to 2,000
CFU/ml of milk).
(iv) Dilution of M. bovis BCG in milk. An aliquot of M. bovis
BCG was diluted in PBS–Tween 20 (0.05% Tween 20), and the
mixture was resuspended to match a McFarland 0.1 standard
(bacterial count equivalent to 4 ⫻ 107 CFU/ml). A total of 100
l of this suspension was placed in 900 l of milk (corresponding to 4 ⫻ 107 CFU/ml of milk), and the mixture was serially
diluted to 10⫺3 CFU/ml. The DNA was extracted from these
dilutions as described above. Subsequently, amplification and
detection were performed as described above.
Microtiter plate detection identified less than 1 CFU of M.
bovis/ml of milk by our assay format. This indicates a high
analytical sensitivity for the detection of M. bovis, possibly due
to the presence of four to eight copies of the direct repeat of
the amplification target per organism.
Assay performance with liver samples from lemmings experimentally infected with B. abortus 2308 or RB51. The assay
performance was tested with a set of 45 liver samples from
infected lemmings. In total, 33 culture-positive and 12 culturenegative liver samples were tested. Nine of 12 negative samples
were from RB51 (an avirulent vaccine strain)-infected lemmings. These samples were interpreted as being from animals
that had “cleared” the infection. Of the 33 culture-positive
liver samples, 31 were positive by PCR. Therefore, by using
culture as a “gold standard,” the sensitivity of BPDA-PCR was
93.9% (31 of 33 samples). The two PCR-negative, culturepositive samples were from lemmings infected with the avirulent RB51 strain. Among the 12 culture-negative liver samples,
5 (3 from the strain 2308-inoculated group and 2 from the
strain RB51-inoculated group) were identified as positive by
PCR, while the other 7 (all RB51 group) culture-negative
samples were classified as negative by PCR. These experiments
show that the performance of BPDA-PCR may be comparable
to that of culture in that BPDA-PCR identified five culturenegative samples from experimentally lemmings as positive.
These animals may have incompletely cleared the infection
and may thus be carrying damaged organisms that could not be
revived by the conventional culturing method used. Addition-
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ally, identification of infected animals by culture is often difficult because brucellae are fastidious and slow growers.
Duplex identification of B. abortus and/or M. bovis in milk
samples from brucellosis-positive animals sampled in India.
DNA was extracted from the milk of 20 cows from a herd in
Bangalore, India, known to be infected with B. abortus and was
analyzed by BPDA-PCR. Of these 20 milk samples 15 were
milk ring test positive (i.e., positive for B. abortus antibodies).
The PCR analysis identified 13 of the 15 milk ring test-positive
animals and 4 of the 5 milk ring test-negative animals as B.
abortus shedders. The ODs at 450 nm ranged from 0.287 to
0.838 and 0.121 to 0.209 for positive and negative samples,
respectively. The other negative milk ring test-samples and two
milk ring test-positive samples were negative by PCR (Table
1). In addition, upon analysis of these samples by individual
probe (M. tuberculosis complex- or B. abortus-specific) hybridization assays, two samples were found to be positive for
both B. abortus and M. bovis. All other samples were positive
only for B. abortus by BPDA-PCR. These studies further validate the high degree of sensitivity of BPDA-PCR in identifying infected, shedding animals that may be missed by the milk
ring test. BPDA-PCR analysis was also able to identify two
animals concurrently infected with M. bovis and B. abortus.
Duplex PCR identification of B. abortus and/or M. bovis in
milk samples from brucellosis-suspect animals sampled in
Argentina. (i) BPDA-PCR performance with suspected M.
bovis-positive samples. Thirty-two animals from three purified protein derivative-positive farms were tested. The types
of samples tested were milk (n ⫽ 32), nasal swabs (n ⫽ 22),
and retropharyngeal lymph node biopsy specimen (n ⫽ 7).
Only 1 of 32 milk samples and 2 nasal swabs (from two different farms) were positive for M. bovis (positive OD range, 0.241
to 2.842; negative OD range, 0.067 to 0.192). All lymph node
biopsy specimens were negative by tests with both multiple and
individual probes. All samples from one farm suspected of
being positive were negative.
(ii) BPDA-PCR performance with suspected B. abortus-positive samples. Twenty-eight milk samples from brucellosis-positive animals (according to the results of the buffered antigen
plate agglutination [BAPA] test) in two herds were tested.
Seven BAPA test-positive animals tested positive (positive OD
range, 0.219 to 0.518; negative OD range, 0.078 to 0.189) by
BPDA-PCR and were defined as B. abortus shedders by analysis with individual probes (Tables 2 and 3).
(iii) BPDA-PCR performance with milk sample pools. Fourteen milk sample pools (with each pool made up of five samples) were analyzed by BPDA-PCR. From retrospective analysis of individual milk samples, it was expected that 6 of the
14 milk sample pools should be positive. BPDA-PCR analysis
correctly identified four of six milk sample pools as positive.
The two pools in which organisms were not detected were
low-positive pools, in that each of these had a sample that was
borderline positive (ODs of 0.219 and 0.295, respectively, when
individual samples were tested with B. abortus-specific probes).
The results indicate that pooling of samples from five animals
for BPDA-PCR may miss some low-level shedders or lowlevel-positive animals. Additional studies with pools of samples
from three animals or other combinations will be required to
define low-level shedders adequately.
(iv) Internal standard analysis. A total of 125 samples from
Argentina were tested for amplification of a 226-bp region of
bovine ␤2-microglobulin to determine if any samples contained
PCR inhibitors or if the DNA extraction was functionally intact. All samples analyzed by agarose gel electrophoresis of
the amplicon products were shown to have single, nondiffuse
bands with high concentrations of amplicons for the ␤2-micro-
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TABLE 3. Summary of shedding status within M. bovis- or B. abortus-infected herds in two argentine countiesa
No. of farms positive
by BPDA-PCR/no.
of farms tested

Total no. of
animals tested

Total no. of
PCR-positive
animals

% of animals
shedding organism
in milk

M. bovis suspect farms
(PPD positive)

2/3

32

3

3.1% of suspect cows (1/32)

B. abortus suspect farms
(BAPA test positive)

2/2

28

8

Milk pools (see milk
pool summary sheet)

4/6

25% of suspect cows (5/28)
or 11.4% of all cows
tested
42.8% of pools were
positive

Sample source

14 pools of 5 milk samples
each from a total of 70
animals

4

Comments

Nasal swabs alone from two
animals tested positive,
and milk only from one
animal tested positive

Included milk samples from
one “negative” farm; two
pools were false negative;
no false-positive samples
were identified

globulin region of interest. The amplification of the 226-bp
region from all samples indicates no PCR inhibition or DNA
degradation; therefore, any BPDA-PCR-negative sample was
considered to be from a nonshedder or to contain organisms at
a level below the detection limits of the assay.
Identification of M. bovis in milk samples or nasal swabs
from skin test-positive herds sampled in Mexico. Two sets of
samples from Mexico were analyzed. One set consisted of milk
samples from animals from caudal fold tuberculin test- and
comparative cervical test-positive farms. Forty-six milk sample
pools were tested. Each pool was a mixture of milk from 10
individual animals. Of the 46 milk sample pools, 15 were positive (positive OD range, 0.241 to 1.124) with the BPDA-PCR
multiplex probe- and M. tuberculosis complex-specific probecoated microtiter plates. Retrospective analysis of all 10 individual milk samples from one positive pool identified two positive animals. The second set of samples analyzed included
nasal swabs (n ⫽ 121) obtained from a second geographically
distinct area in Mexico. Of the 121 samples, 68 (56.2%) were
BPDA-PCR-positive for M. bovis (OD range, 0.406 to 2.882).
Animals from these farms were also bovine TB suspect on the
basis of intradermal test results.
DISCUSSION
Economics of disease eradication and the need for an accurate tool. The presence of infection caused by the two zoonotic
pathogens, B. abortus and M. bovis, in animal populations
poses an economic threat to countries around the world (1, 5,
6, 7, 24). This disease has contributed to nontariff trade barriers by impeding the safe, free trade of cattle and cattle products implemented by international and other national trade
agreements (6). Losses due to reduced sales and lowered production and the trade barrier that these diseases have created
reemphasize the need for a rapid, sensitive, specific, and efficient molecular biology-based diagnostic tool. This would
eventually lead to reduced rates of M. bovis and B. abortus
infection and therefore an increase in the trade, movement,
and marketability of cattle in South, Central, and North America. Countries in these regions look to the United States for
technologies and protocols that they can use to aid them with
their screening for such zoonoses and to initiate profitable
livestock trading across international borders. On the basis of
the prevalence data from the three countries surveyed (5, 6, 36;
Miolan-Suazo et al., Proc. USAHA Meeting), an algorithm for
an eradication program is proposed (Fig. 2). The algorithm

includes the need for a stepwise, multistage, periodic testing
process for a successful eradication program. The algorithm
allows the testing of milk samples in pools made up of milk
from 5 to 10 animals in each pool in high-incidence areas, thus
reducing the cost of screening each animal. As demonstrated
in the samples from Mexico, analysis of pools made up of 5 to
10 milk samples is feasible and will help identify positive samples as a part of the proposed eradication algorithm.
Current diagnostic practices and their pitfalls. Diagnosis of
brucellosis primarily uses the milk ring test or the BAPA test.
The milk ring test or the BAPA test has been widely applied
for identification of infected herds in the United States and
other countries, followed by ELISA, the complement fixation
test, or the standard tube agglutination test to confirm infection in individual animals (2, 5, 33). The milk ring test is an
agglutination test with fair specificity (79.4 to 86.7%) and sensitivity (85.4 to 99.3%) (32). False-positive results by the milk
ring test occur immediately after parturition and during mastitis. Additionally, batch-to-batch variations in milk ring test
antigen levels lead to variability associated with the lower sensitivity of the assay (P. H. Elzer, personal communication). The
results indicate that the milk ring test may be less sensitive than
PCR. On the other hand, while ELISAs have proved to have
higher sensitivities and specificities, like the milk ring test they
measure antibodies that reflect exposure of the animal to brucellae and do not necessarily indicate present infection or the
ability of the animal to spread the disease (5). Despite some of
these drawbacks, the two serological tests have been used in
successful eradication schemes. Additionally, these tests can be
used as an initial screen to identify exposed or infected herds
in an eradication program.
PCR with random or selected primers has shown promising
results, but large-scale field validations and evaluations are
lacking, especially for detection of chronic infections. For
PCR, various targets (species-specific, biotype-specific, and
genus-specific targets) have been investigated, including the
genes for Omp2 (12), the 31-kDa (BCSP31K) antigen (22), the
16S rRNA, the 16S-23S spacer region, and an insertional element, namely, IS711 (3, 4). Among these, the gene that encodes a 31-kDa protein has proved to be a promising target
because of the presence of species-specific signature regions in
the gene (22). In the past there has been considerable interest
in the use of rapid molecular biology-based assays to identify
and determine the species of brucellae (3, 4, 5). By using this
strategy with species-specific signature regions on Omp2 gene
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(12), a PCR assay has been developed and patented (T. A.
Ficht, B. A. Sowa, and L. G. Adams, May 1994, U.S. patent
5310649). The antigen detection methods are potentially useful but have not been validated. Combinations of these with
PCR, such as immuno-PCR, have considerable potential but
require evaluation (5).
Recent developments in the molecular genetics of mycobacteria have identified species-specific markers in MPT40 (27),
oxyR (30), and pncA (9) that enable specific identification of M.
bovis. Among these, only the oxyR polymorphism at nucleotide
285 has proved to be an accurate and consistent M. bovisspecific marker (9). Other targets that have been investigated
include the 16S rRNA gene region with a TB complex-specific
signature sequence, targets identified by randomly amplified
polymorphic DNA analysis (18, 26, 28, 29), and mycolic acid
profiles identified by the high-performance liquid chromatography (13). The high-performance liquid chromatography
method requires a considerable bacterial inoculum, thereby
requiring mycobacterial culture, which takes 3 to 6 weeks,
before application.
It may be argued that IS6110 has more copies and would
form a good target for the identification of M. tuberculosis
complex organisms. However, numerous ancestral isolates
from the M. tuberculosis complex group (especially M. bovis
from cattle, goats, or other animal sources and some M. tuberculosis isolates from certain geographic localities that have now
spread globally) with no copies of IS6110 exist (31). While the
use of oxyR for the specific identification of M. bovis is very
attractive, oxyR is a pseudogene in the M. tuberculosis complex;
therefore, it is expected under the classical evolutionary theory
that this pseudogene may mutate spontaneously (and at a
higher rate than other structural genes) over time and may not
be detected in some isolates by the use of specific probes. Thus,

the hsp65 region with a direct-repeat sequence, which is present in multiple copies, was used in the present study.
Performance of BPDA-PCR: experimental and field studies.
The experiments performed in the present study with purified
genomic DNA optimized the assay for B. abortus identification
at ⬍2,000 CFU/ml and for M. bovis identification at ⬍10 CFU/
ml. Although the detection level for M. bovis is as low as 4
CFU/ml, we believe that this could be an overestimate due to
the indirect nature of CFU equivalent estimation by the use of
McFarland standards. Overall, experimental studies with either organism proved that the assay was very sensitive and
specific on the basis of the data obtained for normal and spiked
milk samples and liver samples from experimentally infected
lemmings. The performance of BPDD-PCR in field studies
with infected herds from countries that report the occurrence
of the two zoonotic diseases further validates its use as an
optimal tool for surveillance for bovine brucellosis and TB.
One of the concerns with PCR is the occurrence of falsenegative results due to the presence of substances in the sample that interfere with amplification. The extraction process
used in the study efficiently eliminates PCR inhibitors. To test
this, all Argentine specimens and a subset of samples from
Mexico were tested for the presence of a ␤2-microglobulin
segment that is highly conserved and that is expected to be
present in host cellular debris of any secretion or excretion. All
samples tested positive for ␤2-microglobulin, thus increasing
the degree of confidence in the technical interpretation of a
negative test result as “negative.” On the other hand, falsepositive results may occur as a result of the cross-reactivity of
PCR primers and probes or because of contamination during
any stage of collection, processing, and detection. Therefore, a
series of database searches was performed to identify specific
regions for primer and probe design. Additionally, the study
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FIG. 2. Proposed algorithm for a stepwise repeat sampling and testing protocol for a disease eradication scheme. The proportion of animals to be tested will vary
with the prevalence of disease in a given geographic locality (higher numbers in lower-prevalence areas; however, low-prevalence areas will not require many iterations
of the same tests).
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used a hygienic milk collection protocol and laboratory procedures to minimize cross contamination of samples. This is
reflected by the fact that all negative samples (from diseasefree herds) and controls yielded ODs below the cutoff value.
The surveillance and monitoring algorithm proposed in this
study emphasizes a multistage identification system because
PCR identifies animals actively shedding the organism and
contaminating the environment. Thus, a negative PCR result
should be interpreted with caution, especially with a chronic
granulomatous disease such as bovine TB.
However, PCR results are similar to culture results. A positive PCR test indicates the presence of the pathogen, and this
is often correlated with infectivity. In the context of infections
with M. bovis, a positive PCR result represents a status in
which the animal has been infected, is shedding mycobacteria
or brucellae, and may infect other animals, but a negative
result does not rule out infection. A similar argument can be
made about culture, since not all attempts to culture an organism are successful, and not all samples provide sufficient material to demonstrate positivity. However, BPDA-PCR is extremely sensitive, and this sensitivity lessens the probability of
false-negative results. Sample volumes have been optimized in
this study to reduce sampling error, and our data show that
⬍10 organisms (BCG serial dilution studies) may be detectable
in 1 ml of a milk sample pool. Others have also shown that
PCR detects as few as one organism (5 fg of DNA or less) in
a specimen aliquot (13, 34).
Miller et al. (24) demonstrated that PCR is effective in
diagnosing TB in cattle with various tissues collected at necropsy. They found a 93% success rate compared with the results of necropsy examination for the detection of ruminant TB
with paraffin-embedded tissues (23). A recent study by Vitale
et al. (34) addressed the performance of PCR versus those of
necropsy examination for infection and conventional test result. Using PCR analysis of tissues from slaughtered animals as
a gold standard in an evaluation of 100 cattle, they showed
100% sensitivity and specificity for milk samples and lymph
node biopsy specimens (collected at necropsy). The lack of
PCR-positive lymph node biopsy specimens by BPDA-PCR in
our study may be associated with the fact that the representative nodes were not sampled. In most instances appropriate
lymph nodes are not superficially accessible for optimal diagnosis of infection by PCR or culture. Additionally, it is suggested that multiple nodes must be sampled for M. tuberculosis
complex-specific PCR to improve the diagnostic value (6, 25).
Technical difficulties and the stress imposed on the animals,
which may reduce milk production, make it somewhat impractical for the use of lymph node biopsy specimens for antemortem diagnostic assays.
Although historical data for the detection of B. abortus bacteremia for as long as 251 days in nonvaccinated animals and
60 days in vaccinated animals exists (21), most animals in
advanced carrier states also shed organisms in their milk.
Blood sampling is useful for early detection of the disease
process, while BPDA-PCR analysis of milk will efficiently detect most (⬎90%) chronically infected animals in the herd.
Thus, the optimal sampling strategy may be to use milk alone
for the diagnosis of brucellosis and nasal swabs in addition to
milk for the diagnosis of bovine TB. Studies by Vitale et al.
(34) and Cornejo et al. (6) for bovine TB and those by LealKlevezas et al. (17) and Fekete et al. (11) for bovine brucellosis
support the idea that the use of milk and/or nasal swab specimens may be optimal for the efficient diagnosis of the diseases
caused by these two zoonotic pathogens. BPDA-PCR does
identify but cannot differentiate vaccine strains of B. abortus
(S19 and RB51) when they are present. Given that only calf-

hood vaccination with strains S19 and RB51 is practiced and
that strain RB51 is not excreted or cleared from the body in
milk, the possibility of false-positive results by BPDA-PCR due
to vaccination is significantly reduced.
The use of PCR for the diagnosis of bovine infections has
not been evaluated in large-scale field or herd studies so that
guidelines for its use in an eradication program can be recommended. Although there are limited data from studies with
animal isolates (6, 34), to our knowledge, this is the first study
to test the ability of a multiplex molecular biology-based assay
to detect any animal disease in the field. Such an assay, when
available for large-scale disease screening and surveillance, is
very appealing because of its ability to identify the presence of
multiple pathogens in herds as well as in individual animals.
This multiplex format further translates into a lower cost per
pathogen tested per herd. In conclusion, the ability of BPDAPCR to identify either pathogen in field samples from herds
from a variety of geographic regions known to be infected or
exposed to the pathogens demonstrates that the test is robust
and accurate. Use of a combination of the duplex PCR assay,
screening of milk samples in pools, and the proposed algorithm
provides a highly sensitive and economically viable alternative
to immunodiagnostic methods.
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